Lv6
2670 积分 2022-05-19 加入
Structural basis for the recognition of IFNAR1 by the humanized therapeutic monoclonal antibody QX006N for the treatment of systemic lupus erythematosus
4天前
已完结
Structural basis for the recognition of IFNAR1 by the humanized therapeutic monoclonal antibody QX006N for the treatment of systemic lupus erythematosus
26天前
已完结
Structural basis for the recognition of IFNAR1 by the humanized therapeutic monoclonal antibody QX006N for the treatment of systemic lupus erythematosus
26天前
已关闭
Abstract 5333: NeoMab: A novel platform for fully human therapeutic antibody development
1个月前
已关闭
Assessing the clinical progress of the bispecific nanobody sonelokimab
2个月前
已完结
A Novel Designed Anti–PD-L1/OX40 Bispecific Antibody Augments Both Peripheral and Tumor-Associated Immune Responses for Boosting Antitumor Immunity
4个月前
已完结
Single-Domain Antibodies
5个月前
已完结
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
7个月前
已完结
皖公网安备34019202002308
